Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Azole resistance in Aspergillus fumigatus has emerged as a global health problem.
Although the number of cases of azole-resistant aspergillosis is still limited, resistance …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Aspergillus fumigatus is one of the most ubiquitous of the airborne saprophytic fungi.
Humans and animals constantly inhale numerous conidia of this fungus. The conidia are …

Aspergillus species have emerged as an important cause of life-threatening infections in
immunocompromised patients. This expanding population is composed of patients with …

The health-care facility environment is rarely implicated in disease transmission, except
among patients who are immunocompromised. Nonetheless, inadvertent exposures to …

Major developments in research into the azole class of antifungal agents during the 1990s
have provided expanded options for the treatment of many opportunistic and endemic fungal …

Since the first description of invasive aspergillosis as an opportunistic infection in 1953 [1],
there has been a substantial increase in the number of cases documented at autopsy in all …

This report updates, expands, and replaces the previously published CDC" Guideline for
Prevention of Nosocomial Pneumonia". The new guidelines are designed to reduce the …

We describe 18 nonimmunocompromised patients with chronic pulmonary aspergillosis.
Duration of the disease ranged from several months to> 12 years. All 18 patients had prior …